Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis | NEJM
Rheumatology Clinal Research - Carolina Arthritis
Lupus Conversations: Let's Talk About Lupus, Clinical Trials, and Race - Rheumatology Nurses Society
Clinical Trials | Rheumatology
Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review
Oncology Clinical Trials Office (OCTO) — Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti- rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial - The Lancet
Materials to Increase Minority Participation in Clinical Trials
Transforming clinical trials in rheumatology: towards patient-centric precision medicine | Nature Reviews Rheumatology
Clinical Trials | Rheumatology
Novel rheumatoid arthritis drug succeeds in clinical trial | News Center | Stanford Medicine
Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis | NEJM
ARN Clinical Research Organization - American Rheumatology Network
All Studies - Clinical Trials of Texas
Clinical Trials | USF Health
PDF) Kavitha Mohanasundaram Avant Garde Clinical Trials in Rheumatology
JCM | Free Full-Text | Clinical Trials in Chronic Arthritic Diseases with Underestimated Impact of Placebo Effects on Study Size Calculation